Drugs / hydrocortisone probutate
hydrocortisone probutate
also known as
Hydrocortisone buteprate · Hydrocortisone butyrate propionate · Hydrocortisone probutat · Pandel · TS 408
Small molecule targets NR3C1 via activation
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | PANDEL | — | 2017-01-25 | fda.gov ↗ |
| Approved | US (FDA) | PANDEL | — | 1997-02-28 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01137032 | Jun 2004 → Aug 2005 | atopic eczema, psoriasis | Fougera Pharmaceuticals Inc. | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hydrocortisone probutate | “Pandel® (hydrocortisone probutate cream)” NCT01137032 ↗ |
| Known as | Hydrocortisone buteprate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200953 ↗ |
| Known as | Hydrocortisone butyrate propionate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200953 ↗ |
| Known as | Hydrocortisone probutat | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200953 ↗ |
| Known as | Pandel | “Pandel® (hydrocortisone probutate cream)” NCT01137032 ↗ |
| Known as | TS 408 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200953 ↗ |
| Action | Activate | “Glucocorticoid receptor agonist” CHEMBL1200953 ↗ |
| Modality | Small molecule | — CHEMBL1200953 ↗ |
| Route | Topical | “A thin coat of cream will be applied and rubbed into the affected areas, as well as normal skin” NCT01137032 ↗ |
| Target | NR3C1 | “Glucocorticoid receptor agonist” CHEMBL1200953 ↗ |